Nifedipine Antitrust Case: Court Finds No "Immediate Threat" To Purchasers
This article was originally published in The Pink Sheet Daily
Executive Summary
Citing a Federal Trade Commission consent order on Adalat CC generics, D.C. federal judge dismisses claims for injunctive relief filed by wholesalers, retailers and payors against Biovail, Elan and Teva. Court allows damages claims based upon antitrust violations to proceed.